Staphylococcus aureus with reduced susceptibility to vancomycin isolated from a patient with fatal bacteremia

Emerging Infectious Diseases

Volumn 5, Issue 1, 1999, Pages 147-149

  Rotun, Sharon S ^a   McMath, Virginia ^a   Schoonmaker, Dianna J ^d,e   Maupin, Peggy S ^b   Tenover, Fred C ^c   Hill, Bertha C ^c   Ackman, David M ^b  

^a United Hospital Medical Center   (United States)

^b NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d WADSWORTH CENTER   (United States)

^e Our Lady of Mercy Cancer Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; COAGULASE NEGATIVE STAPHYLOCOCCUS; HUMAN; LATEX AGGLUTINATION TEST; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

EID: 0032977001     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0501.990118     Document Type: Article

References (7)

1. Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 1997,40:135-6.
2. Staphylococcus aureus with reduced susceptibility to vancomycin - United States. MMWR Morb Mortal Wkly Rep 1997;46:765-6.
3. Etest package insert. AB Biodisk North America., Piscataway, NJ. 1996.
4. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 4th ed. Vol 17, no. 2, Approved Standard M7-A4, National Committee for Clinical Laboratory Standards, Wayne, PA. 1998.
5. National Committee for Clinical Laboaratory Standards. Performance standards for antimicrobial disk susceptibility tests. 6th ed. Vol. 17, no. 1. Approved Standard M2-A6, National Committee for Clinical Laboratory Standards, Wayne, PA. 1998.
6. Tenover FC, Lancaster MV, Hill BC, Steward CD, Stocker SA, Hancock GA, et al. Charactenzation of Staphylococci with reduced susceptibilities to vancomycin and other glycopeptides. J Clin Microbiol 1998;36:1020-7.
7. Daum RS, Gupta S, Sabbagh R, Milewski WM. Characterization of Staphylococcus aureus isolates with decreased susceptibility to vancomycin and teicoplanin: isolation and purification of a constitutively produced protein associated with decreased susceptibility. J Infect Dis 1992;166:1066-72.